Compare StocksCRM vs ELV

Salesforce, Inc. (CRM) vs Elevance Health, Inc. (ELV): Which Is the Better Buy in 2026?

As of 2026-06-19, CRM is undervalued at $152, with a DCF intrinsic value of $274 and a margin of safety of 45%. ELV is undervalued at $389, with an intrinsic value of $662 and a margin of safety of 41%. Of the two, CRM has the wider margin of safety.

CRM
Salesforce, Inc.
$151.78
VS
ELV
Elevance Health, Inc.
$388.50

Rewards

CRM
  • Gross margin of 77.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Free cash flow has grown at a 31.6% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $5.53 of earning power — management is an exceptional capital allocator.
ELV
  • Elevance Health, Inc. scores 95/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Net debt/EBITDA of -0.6x means the company holds more cash than debt — a net cash position.

Risks

CRM
    ELV
    • FCF yield of 5.1% suggests reasonable valuation assuming continued moderate growth.
    • Free cash flow has declined at a 24.1% CAGR over the past 4 years — a concerning trend.

    Key Valuation Metrics

    Learn more →
    CRM
    ELV
    Valuation
    $16.55B
    Free Cash Flow
    $4.30B
    13.32%
    FCF Yield
    5.10%
    17.57
    Trailing P/E
    16.47
    9.77
    Forward P/E
    13.28
    Quality & Moat
    9.61%
    ROIC
    11.06%
    16.91%
    ROE
    12.09%
    77.64%
    Gross Margin
    25.89%
    0.77
    PEG Ratio
    1.46
    Balance Sheet Safety
    0.90
    Net Debt / Equity
    Net cash
    N/A
    Interest Coverage
    N/A
    2.38
    Net Debt / EBITDA
    -0.61
    1.09%
    Dividend Yield
    1.73%
    CRM: 6Ties: 1ELV: 5
    CRMELV

    Historical Fundamentals

    Learn more →
    CRM

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    ELV

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    CRM
    $-7.99
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $14.67B
    Δ Market Cap
    $-117.14B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    ELV
    $-3.39
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $13.20B
    Δ Market Cap
    $-44.69B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    CRM
    44.5% Margin of Safety
    Price is 44.5% below estimated fair value
    Current Price: $151.78
    Fair Value: $273.71
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    ELV
    41.3% Margin of Safety
    Price is 41.3% below estimated fair value
    Current Price: $388.50
    Fair Value: $661.50
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    CRM

    What growth rate is the market pricing in at $152?

    +3.6%
    Market-Implied Owner Earnings Growth
    Standard FCF implies -2.8%

    The market implies +3.6% Owner Earnings growth, below historical trends — potential opportunity.

    Standard FCF implies a more demanding -2.8%, reflecting heavy growth investment expected to generate future returns.

    ELV

    What growth rate is the market pricing in at $389?

    +1.8%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +6.6%

    The market implies +1.8% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +6.6%, reflecting heavy growth investment.

    Economic Moat Score

    Learn more →
    CRM
    58/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    ELV
    95/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

    Forensic Accounting

    Learn more →
    CRM
    -2.73
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    ELV
    -2.21
    Possible Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    CRM
    Insiders 3.0%Institutions 94.3%Retail & Other 2.8%
    No. of Institutional Holders3,722
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    ELV
    Insiders 0.2%Institutions 93.4%Retail & Other 6.4%
    No. of Institutional Holders2,005
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    CRM
    0
    Buys (3M)
    5
    Buys (12M)
    Total value (12M): $27.38M
    ALBER LAURA
    Director
    $500,266
    @ $194.58 · 2026-03-19
    KIRK DAVID BLAIR
    Director
    $500,178
    @ $194.62 · 2026-03-18
    KIRK DAVID BLAIR
    Director
    $500,722
    @ $258.64 · 2025-12-17
    MORFIT G MASON
    Director and Beneficial Owner of more than 10% of a Class of Security
    $25.02M
    @ $260.58 · 2025-12-05
    KIRK DAVID BLAIR
    Director
    $865,827
    @ $254.66 · 2025-09-09
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    ELV
    0
    Buys (3M)
    3
    Buys (12M)
    Total value (12M): $3.68M
    COLLIS STEVEN H
    Director
    $869,520
    @ $289.84 · 2026-03-05
    DEVORE SUSAN D
    Director
    $374,580
    @ $312.15 · 2025-08-19
    BOUDREAUX GAIL A KOZIARA
    Chief Executive Officer
    $2.44M
    @ $286.94 · 2025-07-18
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    CRM
    0
    Sells (3M)
    15
    Sells (12M)
    Total value (12M): $40.30M
    KROES NEELIE
    Director
    $929,276
    @ $238.70 · 2026-01-14
    HARRIS G PARKER
    Officer and Director
    $31.61M
    @ $234.70 · 2025-12-02
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $575,140
    @ $255.62 · 2025-10-23
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $590,102
    @ $262.27 · 2025-10-21
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $567,631
    @ $252.28 · 2025-10-20
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $550,430
    @ $244.64 · 2025-10-17
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $558,810
    @ $248.36 · 2025-10-16
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $536,322
    @ $238.37 · 2025-10-15
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $548,796
    @ $243.91 · 2025-10-14
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $1.10M
    @ $244.75 · 2025-10-13
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $547,344
    @ $243.26 · 2025-10-09
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $539,533
    @ $239.79 · 2025-10-08
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $555,001
    @ $246.67 · 2025-09-23
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $552,798
    @ $245.69 · 2025-09-19
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $545,384
    @ $242.39 · 2025-09-15
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    ELV
    3
    Sells (3M)
    5
    Sells (12M)
    Total value (12M): $1.74M
    PENCZEK RONALD W
    Officer
    $148,766
    @ $403.16 · 2026-06-12
    DIXON ROBERT L JR
    Director
    $60,667
    @ $401.77 · 2026-06-11
    PENCZEK RONALD W
    Officer
    $617,192
    @ $403.13 · 2026-05-19
    SCHULMAN AMY W.
    Director
    $7,475
    @ $287.50 · 2026-03-12
    KENDRICK CHARLES MORGAN JR
    Officer
    $910,604
    @ $284.92 · 2026-03-06
    KAYE MARK
    Chief Financial Officer
    $1.95M
    @ $424.82 · 2025-04-24
    PENCZEK RONALD W
    Officer
    $183,903
    @ $415.13 · 2025-03-10
    KENDRICK CHARLES MORGAN JR
    President
    $1.39M
    @ $396.30 · 2025-03-05
    KENDRICK CHARLES MORGAN JR
    Officer
    $3.21M
    @ $432.14 · 2024-10-18
    PERU RAMIRO G
    Director
    $400,235
    @ $531.52 · 2024-08-05
    BOUDREAUX GAIL A KOZIARA
    Chief Executive Officer
    $17.03M
    @ $500.98 · 2024-07-22
    DIXON ROBERT L JR
    Director
    $154,562
    @ $506.76 · 2024-07-19
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    CRM
    FearGreed
    🥶Extreme Fear(18/100)

    "Mr. Market is panicking — potential buying opportunity if fundamentals are strong"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    ELV
    FearGreed
    😐Neutral(57/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    CRM
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Extreme Fear (18)
    ELV
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (57)
    View CRM Full AnalysisView ELV Full Analysis

    Frequently Asked Questions: CRM vs ELV

    Is Salesforce, Inc. or Elevance Health, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, CRM trades at a 44.5% margin of safety (intrinsic value $274 vs. price $152), compared to ELV's 41.3% margin of safety (intrinsic $662 vs. $389).

    Which stock has a wider economic moat, Salesforce, Inc. or Elevance Health, Inc.?

    ELV scores 95/100 (Wide moat), while CRM scores 58/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is Salesforce, Inc. in financial distress?

    CRM's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. ELV scores 2.6 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which company has better free cash flow, Salesforce, Inc. or Elevance Health, Inc.?

    Salesforce, Inc. (CRM) generates a 13.3% free cash flow yield, compared to Elevance Health, Inc.'s 5.1%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, Salesforce, Inc. or Elevance Health, Inc.?

    ELV earns 11.1% ROIC versus CRM's 9.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, Salesforce, Inc.'s or Elevance Health, Inc.'s?

    ELV's dividend earns a safety score of 94/100 (Very Safe), compared to CRM's 88/100 (Very Safe). ELV has raised its dividend for 3 consecutive years.

    CRM vs ELV: Which Is the Better Buy in 2026? | SafetyMargin.io